ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,047Medicare Part D Prescriptions Filled, Including Refills

Rank: 104 out of 1006

$853K Total Retail Price of All Prescriptions

Rank: 66 out of 1006

325 Patients Receiving at Least One Drug in Part D
67%Patients 65 Years and Older
86% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 325 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

13% of this provider’s 325 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

2% of this provider’s 6,842 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

38% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$85 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
LISINOPRIL 401 272 1 3
ATORVASTATIN CALCIUM 378 259 2 5
CRESTOR 320 250 3 18
SIMVASTATIN 251 194 4 1
NEXIUM 249 175 5 28
LEVOTHYROXINE SODIUM 245 174 6 2
OMEPRAZOLE 243 154 7 9
FUROSEMIDE 230 190 8 6
SERTRALINE HCL 217 173 9 19
ADVAIR DISKUS 211 138 10 37
TRAMADOL HCL 177 119 11 35
SINGULAIR 177 91 11 82
METFORMIN HCL 162 83 13 10
AMLODIPINE BESYLATE 158 141 14 4
JANUVIA 157 147 15 49
ZOLPIDEM TARTRATE 155 87 16 14
TRICOR 149 82 17 101
DONEPEZIL HCL 147 142 18 17
HYDROCODONE-ACETAMINOPHEN 145 84 S3 19 25
METOPROLOL TARTRATE 142 123 20 7
LANTUS SOLOSTAR 142 100 20 93
RANITIDINE HCL 140 111 22 63
MONTELUKAST SODIUM 126 75 23 125
OXYCODONE-ACETAMINOPHEN 121 36 S2 24 57
CARVEDILOL 115 87 25 36
ALENDRONATE SODIUM 113 107 26 29
BENAZEPRIL HCL 110 81 27 112
ZETIA 107 95 28 51
LANTUS 105 65 29 43
NAMENDA 104 101 30 34
CYCLOBENZAPRINE HCL 103 22 R 31 113
METFORMIN HCL ER 92 54 32 56
LISINOPRIL-HYDROCHLOROTHIAZIDE 91 61 33 38
PROAIR HFA 90 38 34 64
ATENOLOL 89 55 35 13
ACTOS 87 77 36 89
ESCITALOPRAM OXALATE 73 37 37 27
NORTRIPTYLINE HCL 73 42 37 293
GABAPENTIN 69 40 39 20
HYDROXYZINE HCL 68 44 R 40 189
CITALOPRAM HBR 68 41 40 24
OXYCODONE HCL-ACETAMINOPHEN 67 18 S2 42 138
FLUTICASONE PROPIONATE 64 36 43 55
IBUPROFEN 64 0 43 114
METOPROLOL SUCCINATE 62 47 45 12
PRAVASTATIN SODIUM 61 48 46 15
HYDROCHLOROTHIAZIDE 61 41 46 11
PEN NEEDLE 60 40 48 128
BUPROPION HCL SR 58 38 49 174
CLOPIDOGREL 56 43 50 46
SURE COMFORT 56 45 50 264
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.